Malignant NeoplasmNCT01360814
Structured Multidisciplinary Intervention or Standard Medical Care in Improving Quality of Life in Patients Receiving Active Cancer Treatment
An observational study of Malignant Neoplasm, run by Mayo Clinic at 1 site in United States.
Trial summary
This randomized clinical trial studies structured multidisciplinary intervention or standard medical care in improving quality of life (QOL) in patients receiving active cancer treatment. A structured multidisciplinary intervention may improve the QOL in patients receiving treatment for cancer. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Malignant Neoplasm
- What is being tested?
- quality-of-life assessment, telephone-based intervention and questionnaire administration
- Type of treatment
- Surgery or procedure, Lifestyle or therapy programme
- How many people
- 138 participants
- Where
- 1 siteUnited States
- Study dates
- Jan 2005to 2 Jul 2018
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Ability to attend all treatment sessions and follow-up
- Ability to provide written informed consent
- Ability to participate in all aspects of the study
- Initial diagnosis of cancer must have been =< 12 months prior to study entry
- Intermediate to poor prognosis, defined as an expected 5-year survival of 0-50% in the judgment of the physicians entering the patient on the study
- Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) 0, 1, or 2
- >= 1 week of planned cancer treatment at Mayo Clinic
- Has a caregiver also willing to participate
Who cannot join
- Mini-mental state examination (MMSE) scores of < 20
- Expected survival of < 6 months
- Active substance abuse (alcohol or drug)
- Participation in other psycho-social research trials
- Active thought disorder (bipolar illness, schizophrenia, etc.)
- Suicidal intent or plan
Show all 9Show fewer
- In need of psychiatric hospitalization
- Recurrent disease after disease-free interval of > 6 months
- Previous cancer =< 5 years (except non-melanoma skin cancer and/or second cancer diagnosed at approximately the same time as this cancer)
Trial locations and contacts
1 site in 1 country.
About this study
Official title: A Structured Multidisciplinary Intervention to Improve Quality of Life of Patients Receiving Active Oncological Treatment: A Randomized Trial
This randomized clinical trial studies structured multidisciplinary intervention or standard medical care in improving quality of life (QOL) in patients receiving active cancer treatment. A structured multidisciplinary intervention may improve the QOL in patients receiving treatment for cancer. It is not yet known whether structured multidisciplinary intervention is more effective than standard medical care in improving QOL
Read the detailed description
PRIMARY OBJECTIVES:
- To examine the efficacy of a structured multidisciplinary intervention compared to standard medical care on improving the subject's QOL as measured by the Functional Assessment of Cancer Therapy-General global summary score (FACT-G) at 4 weeks (or at end of the intervention), at 27 weeks and at 52 weeks.
SECONDARY OBJECTIVES:
- To examine the effect of a structured multidisciplinary intervention compared to standard medical care on improving the subject's psychosocial functioning as measured by the 11 Linear Analogue Self Assessment (LASA) QOL scales, Profile of Mood States (POMS), the Functional Assessment of Chronic Illness Therapy-Spiritual well-being scale (FACIT-SP), Pittsburgh Sleep Quality Index, the Epworth Sleepiness Scale, the Control Preferences Scale, and Exercise Behaviors at 4 weeks (or at end of intervention), at 27 weeks and at 52 weeks.
II. To examine the effect of a structured multidisciplinary intervention compared to standard medical care on improving the caregiver's QOL as measured by the Caregiver QOL-Cancer scale, and on their psychosocial functioning as measured by the 11 LASA QOL scales and POMS at 4, 27 and 52 weeks.
OUTLINE: Patients are randomized to 1 of 2 groups.
GROUP A: Patients receive six 90-minute sessions of multidisciplinary structured intervention comprising physical therapy, education, a cognitive-behavioral intervention, discussion and support, spiritual reflection, and a relaxation exercise over 2-4 weeks. Caregivers are invited to sessions 1, 3, 4, and 6. Patients may also receive brief telephone contact during the 6 month follow-up period.
GROUP B: Patients receive standard medical care only. Patients may also receive brief telephone contact during the 6 month follow-up period.
After completion of study treatment, patients are followed up at 4 weeks (or at the end of intervention), at 27 weeks, and at 52 weeks.
- Conditions
- Malignant Neoplasm
- Being tested
- quality-of-life assessment, telephone-based intervention, questionnaire administration, counseling intervention, exercise intervention
- Medical subject headings
- Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
quality-of-life assessmentProcedure or surgery
Also called quality of life assessment
Ancillary studies
telephone-based interventionBehavioural
Receive multidisciplinary structured intervention
questionnaire administrationOther
Ancillary studies
counseling interventionOther
Also called counseling and communications studies
Receive multidisciplinary structured intervention
exercise interventionBehavioural
Receive multidisciplinary structured intervention
educational interventionOther
Also called intervention, educational
Receive multidisciplinary structured intervention
telephone-based interventionBehavioural
Receive standard care
standard follow-up careProcedure or surgery
Receive standard care
| Study group | Role | What they receive |
|---|---|---|
| GROUP A (multidisciplinary intervention) | Patients receive six 90-minute sessions of a multidisciplinary structured intervention comprising physical therapy, education, a cognitive-behavioral intervention, discussion and support, spiritual reflection, and a relaxation exercise over 2-4 weeks. Caregivers are invited to sessions 1, 3, 4, and 6. Patients may also receive brief telephone contact during the 6 month follow-up period. Receives: Procedure: quality-of-life assessment; Behavioral: telephone-based intervention; Other: questionnaire administration; Other: counseling intervention; Behavioral: exercise intervention; Other: educational intervention | |
| GROUP B (standard medical care) | Patients receive standard medical care only. Patients may also receive brief telephone contact during the 6 month follow-up period. Receives: Procedure: quality-of-life assessment; Other: questionnaire administration; Behavioral: telephone-based intervention; Procedure: standard follow-up care |
What is being measured
The primary outcome is the main question the study is designed to answer.
Cancer patient's quality of life (QOL) as measured by the FACT-G global summary score
The t-test and Wilcoxon test supplemented by repeated measures analytical procedures (analysis of variance [ANOVA], Generalized Estimating Equations [GEE]) will be used to measure and analyze QOL.
Measured: At baseline and 4, 27, and 52 weeks
Secondary outcomes (2)
On improving the subject's psychosocial functioning as measured by the 11 LASA QOL scales, Profile of Mood States (POMS), the FACIT-SP, Pittsburgh Sleep Quality Index, the Epworth Sleepiness Scale, the Control Preferences Scale, and Exercise Behaviors
The t-test and Wilcoxon test supplemented by repeated measures analytical procedures (analysis of variance [ANOVA], Generalized Estimating Equations [GEE]) will be used to measure and analyze.
Measured: At baseline and 4, 27, and 52 weeks
On improving the caregiver's QOL as measured by the Caregiver QOLCancer scale, and on their psychosocial functioning as measured by the 11 LASA QOL scales and POMS
The t-test and Wilcoxon test supplemented by repeated measures analytical procedures (analysis of variance [ANOVA], Generalized Estimating Equations [GEE]) will be used to measure and analyze
Measured: At baseline and 4, 27 and 52 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 May 2011 (estimated)
- Study startJan 2005
- Primary completion13 Mar 2009
- Study completion2 Jul 2018
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Malignant NeoplasmStudies of the same condition, open and under way.
- More trials run by Mayo ClinicThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 138 participants (actual)
Sponsor and investigators
- Lead sponsor
- Mayo Clinic
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Matthew Clark, Ph.D., Study chair, Mayo Clinic
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01360814
- Sponsor's protocol ID
- MC0491
- Other IDs
- NCI-2011-00670, MC0491, 2314-04
- Status last verified
- May 2019
- First submitted
- 23 May 2011
- Last updated
- 18 Dec 2019
- Results posted
- No
- Data monitoring committee
- Yes
Publications
Chock MM, Lapid MI, Atherton PJ, Kung S, Sloan JA, Richardson JW, Clark MM, Rummans TA. Impact of a structured multidisciplinary intervention on quality of life of older adults with advanced cancer. Int Psychogeriatr. 2013 Dec;25(12):2077-86. doi: 10.1017/S1041610213001452. Epub 2013 Sep 4.
PubMed 24001635
Study at a glance
From the registry record, last updated by the sponsor on 18 Dec 2019. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Structured Multidisciplinary Intervention to Improve Quality of Life of Patients Receiving Active Oncological Treatment: A Randomized Trial
- ClinicalTrials.gov ID
- NCT01360814
- Acronym / sponsor ID
- MC0491
- Conditions
- Malignant Neoplasm
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 138 participants (actual)
- Lead sponsor
- Mayo ClinicUniversity, hospital or other
- Study start
- Jan 2005 (actual)
- Primary completion
- 13 Mar 2009 (actual)
- Study completion
- 2 Jul 2018 (actual)
- First posted
- 26 May 2011 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This randomized clinical trial studies structured multidisciplinary intervention or standard medical care in improving quality of life (QOL) in patients receiving active cancer treatment. A structured multidisciplinary intervention may improve the QOL in patients receiving treatment for cancer. It is not yet known whether structured multidisciplinary intervention is more effective than standard medical care in improving QOL
Detailed description
PRIMARY OBJECTIVES:
- To examine the efficacy of a structured multidisciplinary intervention compared to standard medical care on improving the subject's QOL as measured by the Functional Assessment of Cancer Therapy-General global summary score (FACT-G) at 4 weeks (or at end of the intervention), at 27 weeks and at 52 weeks.
SECONDARY OBJECTIVES:
- To examine the effect of a structured multidisciplinary intervention compared to standard medical care on improving the subject's psychosocial functioning as measured by the 11 Linear Analogue Self Assessment (LASA) QOL scales, Profile of Mood States (POMS), the Functional Assessment of Chronic Illness Therapy-Spiritual well-being scale (FACIT-SP), Pittsburgh Sleep Quality Index, the Epworth Sleepiness Scale, the Control Preferences Scale, and Exercise Behaviors at 4 weeks (or at end of intervention), at 27 weeks and at 52 weeks.
II. To examine the effect of a structured multidisciplinary intervention compared to standard medical care on improving the caregiver's QOL as measured by the Caregiver QOL-Cancer scale, and on their psychosocial functioning as measured by the 11 LASA QOL scales and POMS at 4, 27 and 52 weeks.
OUTLINE: Patients are randomized to 1 of 2 groups.
GROUP A: Patients receive six 90-minute sessions of multidisciplinary structured intervention comprising physical therapy, education, a cognitive-behavioral intervention, discussion and support, spiritual reflection, and a relaxation exercise over 2-4 weeks. Caregivers are invited to sessions 1, 3, 4, and 6. Patients may also receive brief telephone contact during the 6 month follow-up period.
GROUP B: Patients receive standard medical care only. Patients may also receive brief telephone contact during the 6 month follow-up period.
After completion of study treatment, patients are followed up at 4 weeks (or at the end of intervention), at 27 weeks, and at 52 weeks.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| GROUP A (multidisciplinary intervention) | – | Procedure: quality-of-life assessment, Behavioral: telephone-based intervention, Other: questionnaire administration, Other: counseling intervention, Behavioral: exercise intervention, Other: educational interventionPatients receive six 90-minute sessions of a multidisciplinary structured intervention comprising physical therapy, education, a cognitive-behavioral intervention, discussion and support, spiritual reflection, and a relaxation exercise over 2-4 weeks. Caregivers are invited to sessions 1, 3, 4, and 6. Patients may also receive brief telephone contact during the 6 month follow-up period. |
| GROUP B (standard medical care) | – | Procedure: quality-of-life assessment, Other: questionnaire administration, Behavioral: telephone-based intervention, Procedure: standard follow-up carePatients receive standard medical care only. Patients may also receive brief telephone contact during the 6 month follow-up period. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (8 listed)
- Ability to attend all treatment sessions and follow-up
- Ability to provide written informed consent
- Ability to participate in all aspects of the study
- Initial diagnosis of cancer must have been =< 12 months prior to study entry
- Intermediate to poor prognosis, defined as an expected 5-year survival of 0-50% in the judgment of the physicians entering the patient on the study
Key exclusion criteria (9 listed)
- Mini-mental state examination (MMSE) scores of < 20
- Expected survival of < 6 months
- Active substance abuse (alcohol or drug)
- Participation in other psycho-social research trials
- Active thought disorder (bipolar illness, schizophrenia, etc.)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| quality-of-life assessmentAlso: quality of life assessmentAncillary studies | Procedure or surgery | GROUP A (multidisciplinary intervention), GROUP B (standard medical care) |
| telephone-based interventionReceive multidisciplinary structured intervention | Behavioural | GROUP A (multidisciplinary intervention) |
| questionnaire administrationAncillary studies | Other | GROUP A (multidisciplinary intervention), GROUP B (standard medical care) |
| counseling interventionAlso: counseling and communications studiesReceive multidisciplinary structured intervention | Other | GROUP A (multidisciplinary intervention) |
| exercise interventionReceive multidisciplinary structured intervention | Behavioural | GROUP A (multidisciplinary intervention) |
| educational interventionAlso: intervention, educationalReceive multidisciplinary structured intervention | Other | GROUP A (multidisciplinary intervention) |
| telephone-based interventionReceive standard care | Behavioural | GROUP B (standard medical care) |
| standard follow-up careReceive standard care | Procedure or surgery | GROUP B (standard medical care) |
Primary outcome
Cancer patient's quality of life (QOL) as measured by the FACT-G global summary score
Time frame: At baseline and 4, 27, and 52 weeks
The t-test and Wilcoxon test supplemented by repeated measures analytical procedures (analysis of variance [ANOVA], Generalized Estimating Equations [GEE]) will be used to measure and analyze QOL.
2 secondary outcomes
On improving the subject's psychosocial functioning as measured by the 11 LASA QOL scales, Profile of Mood States (POMS), the FACIT-SP, Pittsburgh Sleep Quality Index, the Epworth Sleepiness Scale, the Control Preferences Scale, and Exercise Behaviors
Time frame: At baseline and 4, 27, and 52 weeks
On improving the caregiver's QOL as measured by the Caregiver QOLCancer scale, and on their psychosocial functioning as measured by the 11 LASA QOL scales and POMS
Time frame: At baseline and 4, 27 and 52 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Dec 2019.
- Derived from this study: PubMed 24001635Chock MM, Lapid MI, Atherton PJ, Kung S, Sloan JA, Richardson JW, Clark MM, Rummans TA. Impact of a structured multidisciplinary intervention on quality of life of older adults with advanced cancer. Int Psychogeriatr. 2013 Dec;25(12):2077-86. doi: 10.1017/S1041610213001452. Epub 2013 Sep 4.
Related trials for Malignant Neoplasm
RecruitingPhase 3
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Ovarian Neoplasms, Fallopian Tube Neoplasms
RecruitingEarly Phase 1
Intratumoral Extracellular Metabolic Impact of DFMO and AMXT 1501 in Patients With Diffuse or High Grade Glioma
Diffuse Glioma, Malignant Glioma
RecruitingPhase 2
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma
RecruitingObservational study
Salivary IL-8 and Serum IL-6 as Biomarkers for Oral Potentially Malignant Disorders in Smokers and Never-Smokers
Oral Potentially Malignant Disorders, Oral Lichen Planus
RecruitingObservational study
Novel Bipolar Radiofrequency Ablation Knife in Esophageal Lesions
Esophageal Neoplasm, Esophageal Polyp
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Matthew Clark, Ph.D. study chair
Mayo Clinic
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Malignant Neoplasm, run by Mayo Clinic at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 18 Dec 2019. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Cancer patient's quality of life (QOL) as measured by the FACT-G global summary score (time frame: At baseline and 4, 27, and 52 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01360814, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Dec 2019.